source · text/csv
source_7f130a3324d4492b
sha256 2a594b6a195b2a5f3f2c925a022fd59ded59c0540189afdbe1ab2ad26bf1041b
by researka:v2 · 2026-06-05 02:16:53.118574+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity The STEP 4 Randomized Clinical Trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Efficacy and safety of once‐weekly subcutaneous semaglutide on weight loss in patients with overweight or obesity without diabetes mellitus—A systematic review and meta‐analysis of randomized controlled trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "347a8b09-fb77-4dd7-9fa6-eb1d0c767f9f",
"researka_submission_id": "87768b3b-a60f-46eb-9d78-1f426b2959f8",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/347a8b09-fb77-4dd7-9fa6-eb1d0c767f9f/sidecars/evidence_table.csv"
}